Corvus Pharmaceuticals, Inc. Operating Leases, Future Minimum Payments, Due in Two and Three Years
Corvus Pharmaceuticals, Inc. (CRVS) had Operating Leases, Future Minimum Payments, Due in Two and Three Years of $2.39 million as of 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoAndThreeYears · last filed 2018-03-01
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Two and Three Years $2.39M.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Two and Three Years $2.32M.
| Period end | Operating Leases, Future Minimum Payments, Due in Two and Three Years |
|---|---|
| 2017-12-31 | $2.39M 10-K · filed 2018-03-01 |
| 2016-12-31 | $2.32M 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |